Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancer.

Subramanian IV, Devineni S, Ghebre R, Ghosh G, Joshi HP, Jing Y, Truskinovsky AM, Ramakrishnan S.

Gene Ther. 2011 Feb;18(2):145-54. doi: 10.1038/gt.2010.118. Epub 2010 Sep 16.

PMID:
20844568
2.
3.

Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice.

Subramanian IV, Ghebre R, Ramakrishnan S.

Gene Ther. 2005 Jan;12(1):30-8.

PMID:
15550927
4.

Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice.

Li J, Dong X, Xu Z, Jiang X, Jiang H, Krissansen GW, Sun X.

J Biomed Sci. 2008 Jan;15(1):99-109. Epub 2007 Aug 18.

PMID:
17705027
5.

Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.

Yokoyama Y, Dhanabal M, Griffioen AW, Sukhatme VP, Ramakrishnan S.

Cancer Res. 2000 Apr 15;60(8):2190-6.

6.

Targeted delivery of an antibody-mutant human endostatin fusion protein results in enhanced antitumor efficacy.

Shin SU, Cho HM, Merchan J, Zhang J, Kovacs K, Jing Y, Ramakrishnan S, Rosenblatt JD.

Mol Cancer Ther. 2011 Apr;10(4):603-14. doi: 10.1158/1535-7163.MCT-10-0804. Epub 2011 Mar 10.

7.

Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.

Zhang X, Xu J, Lawler J, Terwilliger E, Parangi S.

Clin Cancer Res. 2007 Jul 1;13(13):3968-76.

8.

Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.

Inoue K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ, McConkey DJ, Sweeney P, Radinsky R, Dinney CP.

Clin Cancer Res. 2000 Dec;6(12):4874-84.

9.

Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.

Li ZY, Zhu F, Hu JL, Peng G, Chen J, Zhang S, Chen X, Zhang RG, Chen LJ, Liu P, Luo M, Sun ZH, Ren JH, Huang LL, Wu G.

Tumour Biol. 2011 Aug;32(4):677-87. doi: 10.1007/s13277-011-0168-3. Epub 2011 Mar 26.

PMID:
21442281
10.
11.

Inhibition of ovarian cancer by RGD-P125A-endostatin-Fc fusion proteins.

Jing Y, Lu H, Wu K, Subramanian IV, Ramakrishnan S.

Int J Cancer. 2011 Aug 1;129(3):751-61. doi: 10.1002/ijc.25932. Epub 2011 Apr 1.

12.
13.

Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis.

Jiang WG, Lu XA, Shang BY, Fu Y, Zhang SH, Zhou D, Li L, Li Y, Luo Y, Zhen YS.

BMC Cancer. 2013 Oct 15;13:479. doi: 10.1186/1471-2407-13-479.

14.
15.
16.
17.

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.

Chen CT, Lin J, Li Q, Phipps SS, Jakubczak JL, Stewart DA, Skripchenko Y, Forry-Schaudies S, Wood J, Schnell C, Hallenbeck PL.

Hum Gene Ther. 2000 Sep 20;11(14):1983-96.

PMID:
11020798
18.

Therapeutic targeting of angiogenesis with a recombinant CTT peptide-endostatin mimic-kringle 5 protein.

Wang H, Yang Z, Gu J.

Mol Cancer Ther. 2014 Nov;13(11):2674-87. doi: 10.1158/1535-7163.MCT-14-0266. Epub 2014 Aug 15.

19.
20.

Antitumor interaction of short-course endostatin and ionizing radiation.

Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR.

Cancer J. 2000 Sep-Oct;6(5):287-93.

PMID:
11079167

Supplemental Content

Support Center